GDF Welcomes Dr. George Diaz to Medical & Scientific Advisory Board

GDF is pleased to welcome George Diaz, MD, PhD to our Medical & Scientific Advisory Board. Dr. Diaz is Chief of the  Division of Medical Genetics at the Department of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai. He is also the Associate Director of Mount Sinai’s Program for Inherited Metabolic Diseases, one of the largest metabolic disease treatment programs in the country.

For more than 20 years, Dr. Diaz has conducted research focused on the identification of the genetic basis of single gene disorders, with a number of discoveries published to date. His clinical focus is on inborn errors of metabolism and he is a site Principal Investigator for the NIH-funded Urea Cycle Disorders Consortium. He was the lead author on the pivotal study demonstrating the efficacy of a new treatment for urea cycle disorders, glycerol phenylbutyrate, and has been involved in a number of other clinical trials related to other disorders. He has published over 75 peer-reviewed articles and chapters related to his laboratory and clinical research efforts and has presented his work at numerous scientific meetings and hospital grand rounds.

You can read more about Dr. Diaz’s extensive experience at this website and at the Icahn School of Medicine at Mount Sinai website: